Jeffery Shawn Zweizig
Examiner (ID: 11083, Phone: (571)272-1758 , Office: P/2842 )
Most Active Art Unit | 2816 |
Art Unit(s) | 2816, 2849, 2842, 2504 |
Total Applications | 2555 |
Issued Applications | 2334 |
Pending Applications | 90 |
Abandoned Applications | 130 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 6344035
[patent_doc_number] => 20020035101
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-03-21
[patent_title] => 'Method of treating estrogen receptor positive carcinoma 17 alpha-dihydroequilin'
[patent_app_type] => new
[patent_app_number] => 09/962352
[patent_app_country] => US
[patent_app_date] => 2001-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2432
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0035/20020035101.pdf
[firstpage_image] =>[orig_patent_app_number] => 09962352
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/962352 | Method of treating estrogen receptor positive carcinoma with 17 α-dihydroequilin | Sep 25, 2001 | Issued |
Array
(
[id] => 6736067
[patent_doc_number] => 20030013702
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-01-16
[patent_title] => 'Agents and methods for treatment of cancer'
[patent_app_type] => new
[patent_app_number] => 09/961969
[patent_app_country] => US
[patent_app_date] => 2001-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 56897
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0013/20030013702.pdf
[firstpage_image] =>[orig_patent_app_number] => 09961969
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/961969 | Inhibitors of inducible nitric oxide synthase for chemoprevention and treatment of cancers | Sep 23, 2001 | Issued |
Array
(
[id] => 5923512
[patent_doc_number] => 20020115724
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-08-22
[patent_title] => 'Methods and agents for inhibiting protein aging'
[patent_app_type] => new
[patent_app_number] => 09/954514
[patent_app_country] => US
[patent_app_date] => 2001-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 9567
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0115/20020115724.pdf
[firstpage_image] =>[orig_patent_app_number] => 09954514
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/954514 | Methods and agents for inhibiting protein aging | Sep 16, 2001 | Abandoned |
Array
(
[id] => 6362032
[patent_doc_number] => 20020058706
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-05-16
[patent_title] => 'Method for treating asthma using pregabalin'
[patent_app_type] => new
[patent_app_number] => 09/952447
[patent_app_country] => US
[patent_app_date] => 2001-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3227
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0058/20020058706.pdf
[firstpage_image] =>[orig_patent_app_number] => 09952447
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/952447 | Method for treating asthma using pregabalin | Sep 13, 2001 | Abandoned |
Array
(
[id] => 6779257
[patent_doc_number] => 20030050339
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-03-13
[patent_title] => 'Method of administering lactic acid salts to reduce or prevent exertion-related muscle discomfort'
[patent_app_type] => new
[patent_app_number] => 09/950887
[patent_app_country] => US
[patent_app_date] => 2001-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1171
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0050/20030050339.pdf
[firstpage_image] =>[orig_patent_app_number] => 09950887
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/950887 | Method of administering lactic acid salts to reduce or prevent exertion-related muscle discomfort | Sep 9, 2001 | Issued |
Array
(
[id] => 6033683
[patent_doc_number] => 20020019425
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-02-14
[patent_title] => 'p53 Inhibitors and therapeutic use of the same'
[patent_app_type] => new
[patent_app_number] => 09/947757
[patent_app_country] => US
[patent_app_date] => 2001-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 11098
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0019/20020019425.pdf
[firstpage_image] =>[orig_patent_app_number] => 09947757
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/947757 | p53 Inhibitors and therapeutic use of the same | Sep 5, 2001 | Abandoned |
Array
(
[id] => 6673775
[patent_doc_number] => 20030059378
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-03-27
[patent_title] => 'Method of preventing mucositis'
[patent_app_type] => new
[patent_app_number] => 09/948416
[patent_app_country] => US
[patent_app_date] => 2001-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2098
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0059/20030059378.pdf
[firstpage_image] =>[orig_patent_app_number] => 09948416
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/948416 | Method of preventing mucositis | Sep 5, 2001 | Abandoned |
Array
(
[id] => 1399306
[patent_doc_number] => 06531493
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-03-11
[patent_title] => '3-cyclopropylmethoxy-4-difluoromethoxy-N-(3,5-dichloropyrid-4-yl)benzamide in the treatment of multiple sclerosis'
[patent_app_type] => B1
[patent_app_number] => 09/914763
[patent_app_country] => US
[patent_app_date] => 2001-09-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1859
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/531/06531493.pdf
[firstpage_image] =>[orig_patent_app_number] => 09914763
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/914763 | 3-cyclopropylmethoxy-4-difluoromethoxy-N-(3,5-dichloropyrid-4-yl)benzamide in the treatment of multiple sclerosis | Sep 4, 2001 | Issued |
Array
(
[id] => 6344252
[patent_doc_number] => 20020035129
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-03-21
[patent_title] => 'Methods for treating cognitive impairments caused by traumatic brain injuries'
[patent_app_type] => new
[patent_app_number] => 09/947087
[patent_app_country] => US
[patent_app_date] => 2001-09-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4743
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0035/20020035129.pdf
[firstpage_image] =>[orig_patent_app_number] => 09947087
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/947087 | Methods for treating cognitive impairments caused by traumatic brain injuries | Sep 3, 2001 | Issued |
Array
(
[id] => 6082469
[patent_doc_number] => 20020082243
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-06-27
[patent_title] => 'Methods for anti-tumor therapy'
[patent_app_type] => new
[patent_app_number] => 09/941876
[patent_app_country] => US
[patent_app_date] => 2001-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6643
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0082/20020082243.pdf
[firstpage_image] =>[orig_patent_app_number] => 09941876
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/941876 | Methods for anti-tumor therapy | Aug 28, 2001 | Issued |
Array
(
[id] => 7398658
[patent_doc_number] => 20040039047
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-02-26
[patent_title] => 'Compositions and methods for treating lung cancers'
[patent_app_type] => new
[patent_app_number] => 09/928911
[patent_app_country] => US
[patent_app_date] => 2001-08-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 9865
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0039/20040039047.pdf
[firstpage_image] =>[orig_patent_app_number] => 09928911
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/928911 | Compositions and methods for treating lung cancers | Aug 12, 2001 | Abandoned |
Array
(
[id] => 6344342
[patent_doc_number] => 20020035141
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-03-21
[patent_title] => 'Use of melatonin for induction of general anesthesia'
[patent_app_type] => new
[patent_app_number] => 09/927687
[patent_app_country] => US
[patent_app_date] => 2001-08-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3026
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0035/20020035141.pdf
[firstpage_image] =>[orig_patent_app_number] => 09927687
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/927687 | Use of melatonin for induction of general anesthesia | Aug 9, 2001 | Issued |
09/913114 | Gabapentin derivative for preventing and treating visceral pain | Aug 8, 2001 | Abandoned |
Array
(
[id] => 5815283
[patent_doc_number] => 20020040063
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-04-04
[patent_title] => 'Liquid formulation of metformin'
[patent_app_type] => new
[patent_app_number] => 09/923491
[patent_app_country] => US
[patent_app_date] => 2001-08-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8312
[patent_no_of_claims] => 50
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0040/20020040063.pdf
[firstpage_image] =>[orig_patent_app_number] => 09923491
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/923491 | Liquid formulation of metformin | Aug 6, 2001 | Issued |
Array
(
[id] => 6291379
[patent_doc_number] => 20020055457
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-05-09
[patent_title] => 'Methods of treating cancer and the pain associated therewith using endothelin antagonists'
[patent_app_type] => new
[patent_app_number] => 09/923616
[patent_app_country] => US
[patent_app_date] => 2001-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 9484
[patent_no_of_claims] => 58
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0055/20020055457.pdf
[firstpage_image] =>[orig_patent_app_number] => 09923616
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/923616 | Methods of treating cancer and the pain associated therewith using endothelin antagonists | Aug 5, 2001 | Abandoned |
Array
(
[id] => 5800795
[patent_doc_number] => 20020009423
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-01-24
[patent_title] => 'Methods for managing scalp conditions'
[patent_app_type] => new
[patent_app_number] => 09/920729
[patent_app_country] => US
[patent_app_date] => 2001-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9334
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0009/20020009423.pdf
[firstpage_image] =>[orig_patent_app_number] => 09920729
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/920729 | Methods for managing scalp conditions | Aug 2, 2001 | Issued |
Array
(
[id] => 6512115
[patent_doc_number] => 20020025978
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-02-28
[patent_title] => 'Phenylbutazone carrier formulation'
[patent_app_type] => new
[patent_app_number] => 09/920875
[patent_app_country] => US
[patent_app_date] => 2001-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1064
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0025/20020025978.pdf
[firstpage_image] =>[orig_patent_app_number] => 09920875
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/920875 | Phenylbutazone carrier formulation | Aug 2, 2001 | Issued |
Array
(
[id] => 1421076
[patent_doc_number] => 06506791
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2003-01-14
[patent_title] => 'Method of treatment of protozoan infections in fish'
[patent_app_type] => B2
[patent_app_number] => 09/922403
[patent_app_country] => US
[patent_app_date] => 2001-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 3760
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/506/06506791.pdf
[firstpage_image] =>[orig_patent_app_number] => 09922403
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/922403 | Method of treatment of protozoan infections in fish | Aug 2, 2001 | Issued |
Array
(
[id] => 6033338
[patent_doc_number] => 20020019338
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-02-14
[patent_title] => 'Water-soluble salts of 2-difluoromethyl-2,5-diaminopentanoic acid (DFMO)'
[patent_app_type] => new
[patent_app_number] => 09/919692
[patent_app_country] => US
[patent_app_date] => 2001-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2455
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0019/20020019338.pdf
[firstpage_image] =>[orig_patent_app_number] => 09919692
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/919692 | Water-soluble salts of 2-difluoromethyl-2,5-diaminopentanoic acid (DFMO) | Jul 30, 2001 | Issued |
Array
(
[id] => 527779
[patent_doc_number] => RE039480
[patent_country] => US
[patent_kind] => E1
[patent_issue_date] => 2007-01-23
[patent_title] => 'Chromium/biotin treatment of type II diabetes'
[patent_app_type] => reissue
[patent_app_number] => 09/912472
[patent_app_country] => US
[patent_app_date] => 2001-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2011
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/RE/039/RE039480.pdf
[firstpage_image] =>[orig_patent_app_number] => 09912472
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/912472 | Chromium/biotin treatment of type II diabetes | Jul 23, 2001 | Issued |